Enveric Biosciences
Stock Forecast, Prediction & Price Target
Enveric Biosciences Financial Estimates
Enveric Biosciences Revenue Estimates
Enveric Biosciences EBITDA Estimates
Enveric Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $5M Low: $5M High: $5M avg. 0% | Avg: $5M Low: $5M High: $5M avg. 0% | Avg: $15M Low: $15M High: $15M avg. 200% | Avg: $25M Low: $25M High: $25M avg. 66.66% |
Net Income
% change YoY
| $-48.97M N/A | $-18.47M 62.28% | $-17.29K 99.90% | Avg: $-13.80M Low: $-3.04M High: $-1.36M avg. -79742.69% | Avg: $-16.72M Low: $-1.64M High: $-1.64M avg. -21.12% | Avg: $-1.33M Low: $-1.33M High: $-1.33M avg. 91.99% | Avg: $-518.17K Low: $-518.17K High: $-518.17K avg. 61.29% |
EBITDA
% change YoY
| $-26.38M N/A | $-19.52M 26.00% | $-17.13M 12.22% | Avg: $3.89M Low: $3.89M High: $3.89M avg. 122.74% | Avg: $3.89M Low: $3.89M High: $3.89M avg. 0% | Avg: $11.69M Low: $11.69M High: $11.69M avg. 200.00% | Avg: $19.49M Low: $19.49M High: $19.49M avg. 66.66% |
EPS
% change YoY
| -$103.69 N/A | -$12.77 87.68% | -$8.09 36.64% | Avg: -$1.02 Low: -$1.41 High: -$0.63 avg. 87.39% | Avg: -$0.76 Low: -$0.76 High: -$0.76 avg. 25.49% | Avg: -$0.62 Low: -$0.62 High: -$0.62 avg. 18.42% | Avg: -$0.24 Low: -$0.24 High: -$0.24 avg. 61.29% |
Operating Expenses
% change YoY
| $25.94M N/A | $19.96M -23.06% | $16.44M -17.59% | Avg: $4.30M Low: $4.30M High: $4.30M avg. -73.82% | Avg: $4.30M Low: $4.30M High: $4.30M avg. 0% | Avg: $12.91M Low: $12.91M High: $12.91M avg. 200.00% | Avg: $21.52M Low: $21.52M High: $21.52M avg. 66.66% |
FAQ
What is Enveric Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -19902.63% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -3.04M, average is -13.80M and high is -1.36M.
What is Enveric Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 66.66% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $5M, average is $5M and high is $5M.
What is Enveric Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 48.14% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.41, average is -$1.02 and high is $-0.63.